Amicus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.About FOLD
Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio.
CEOBradley Lewis Campbell
CEOBradley Lewis Campbell
Employees499
Employees499
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2002
Founded2002
Employees499
Employees499
FOLD Key Statistics
Market cap2.48B
Market cap2.48B
Price-Earnings ratio-65.63
Price-Earnings ratio-65.63
Dividend yield—
Dividend yield—
Average volume4.30M
Average volume4.30M
High today$8.15
High today$8.15
Low today$7.87
Low today$7.87
Open price$8.07
Open price$8.07
Volume3.12M
Volume3.12M
52 Week high$12.65
52 Week high$12.65
52 Week low$5.51
52 Week low$5.51
FOLD News
Simply Wall St 2d
How Strong Q2 Results and Pipeline Progress at Amicus Therapeutics Have Changed Its Investment StoryAmicus Therapeutics recently reported strong Q2 2025 revenue growth, highlighting key contributions from Galafold and Pompe therapies, and confirmed that full e...
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own FOLD. This list is generated using Robinhood data, and it’s not a recommendation.